Conditions such as pancreatitis or certain thyroid issues may require additional caution when using Semaglutide
On March 20, 2025, the court stated that it was reluctant to enter a decision on the merits without allowing the parties to present further evidence in support of their positions and scheduled a hearing on the joint motion for April 24, 2025
Dysesthesia A notable finding was dysesthesia (an abnormal sensation such as tingling, burning, or numbness), reported in up to 20.9% of participants at the 12 mg dose
However, the other transformative effect of GLP-1 is not just on weight loss
NLRP3 inflammasome activation contributes to aldosterone-induced podocyte injury
Understanding how these medications work and planning for life after discontinuation can help manage this risk